The End of Alzheimer’s: The First Programme to Prevent and Reverse the Cognitive Decline of Dementia
The first proven plan to reverse Alzheimer’s Disease. In The End of Alzheimer’s Dr Dale Bredesen offers real hope to anyone looking to prevent and even reverse Alzheimer’s Disease and the cognitive decline of dementia. Revealing that AD is not one condition but in fact three, he outlines 36 metabolic factors, including micronutrients, hormone levels and sleep, which together can trigger downsizing in the brain.

Dr Bredesen then outlines a proven, step-by-step protocol to rebalance these factors, which patients can follow with the help of a healthcare professional (note: blood tests are required in order to tailor individual plans). There are also general lifestyle and dietary changes all readers can adopt to improve cognitive health.

- Rewrites the science of Alzheimer’s Disease
- Proven step-by-step advice to follow with your doctor
- Offers real hope to patients, carers and health professionals
- The first major breakthrough to stop Alzheimer’s in its tracks

Survival rates in many life-threatening conditions, such as cancer, have been steadily improving for years. But until now nobody had ever survived Alzheimer's Disease. The results, however, of Dr Bredesen’s protocol are impressive: of the first ten patients on the protocol, nine displayed significant improvement within three to six months; since then the protocol has yielded similar results with hundreds more. Dr Bredesen is also focusing on training UK healthcare professionals in his protocol with a further 200 professionals set to receive training this coming spring.

Dale Bredesen, MD, is internationally recognised as an expert in the mechanisms of neurodegenerative diseases, such as Alzheimer's disease. He graduated from Caltech, then earned his MD from Duke University Medical Center in Durham, North Carolina. He served as chief resident in neurology at the University of California, San Francisco (UCSF) before joining Nobel laureate Stanley Prusiner's laboratory at UCSF as an NIH postdoctoral fellow. He held faculty positions at UCSF, UCLA and the University of California, San Diego. Dr Bredesen directed the Program on Aging at the Burnham Institute before joining the Buck Institute in 1998 as its founding president and CEO. He is Professor of Neurology at the University of California, Los Angeles.